Supporting information Figure and Tables.

Survival curves of the three TNF-α inhibitors (Fig. A). Survival rates of the three TNF-α inhibitors (Table A). Predictors of TNF-α inhibitor switching excluding the 9 patients who discontinued TNF-α inhibitors due to adverse events (Table B). Univariate logistic analysis used to evaluate the predictors of complete discontinuation of TNF-α inhibitors (Table C). Comorbid conditions of patients according to whether they subsequently switched or not (Table D). Cox proportional regression analysis used to evaluate predictors of TNF-α inhibitor switching after adjusted for age, gender, disease duration, and BASDAI using propensity score matching (Table E). Baseline characteristics and laboratory findings of patients starting their first TNF-α inhibitor according to TNF-α inhibitor using ANOVA test (Table F). Baseline characteristics and laboratory findings of patients starting their first TNF-α inhibitor according to TNF-α inhibitor using χ2 test (Table G).
(PDF)